BUB1B and cancer: In colon adenocarcinoma, the silencing of BUB1b facilitated oncogenesis and progression, while the opposite phenomenon was observed in hepatocellular carcinoma, pancreatic ductal adenocarcinoma, and other cancers [8, 9].